Accel Wealth Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-20
Closed -$10.8K 279
2023
Q1
$10.8K Hold
20
﹤0.01% 865
2022
Q4
$10.2K Hold
20
﹤0.01% 700
2022
Q3
$9K Hold
20
﹤0.01% 751
2022
Q2
$10K Hold
20
0.01% 700
2022
Q1
$10K Hold
20
0.01% 701
2021
Q4
$11K Hold
20
0.01% 690
2021
Q3
$9K Hold
20
0.01% 659
2021
Q2
$9K Hold
20
0.01% 707
2021
Q1
$9K Hold
20
0.01% 669
2020
Q4
$11K Buy
+20
New +$9.83K 0.01% 593

Other funds holding CHE

Accel Wealth Management's CHE Position: Q2 2023 in Review

Accel Wealth Management sold out of Chemed (CHE) in Q2 2023, closing a stake of 20 shares — an estimated $10.8K sold.

Accel Wealth Management first reported a position in CHE in Q4 2020 and held it in 10 quarters. The position peaked at $11K in Q4 2021. 464 funds tracked by Wall St. Rank hold CHE as of Q2 2023.

  • Accel Wealth Management reported no remaining Chemed position as of Q2 2023 after selling out during the quarter.
  • Accel Wealth Management sold 20 Chemed shares in Q2 2023, an estimated $10.8K.
  • Accel Wealth Management first reported a position in Chemed in Q4 2020 and held it in 10 quarters.
  • Accel Wealth Management's Chemed position peaked at $11K in Q4 2021.
  • 464 funds tracked by Wall St. Rank held Chemed as of Q2 2023.

Based on Accel Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.